(Gln22, Asn23) -Amyloid β-Protein (1-40)

(Gln22, Asn23) -Amyloid β-Protein (1-40) is a peptide. (Gln22, Asn23) -Amyloid β-Protein (1-40) can be used for the research of Cerebral Amyloid Angiopathy Mutations[1].

Product Specifications

CAS Number

[374796-75-5]

UNSPSC

12352209

Target

Amyloid-β

Type

Peptides

Related Pathways

Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/gln22-asn23-amyloid-β-protein-1-40.html

Solubility

10 mM in DMSO

Smiles

O=C([C@@H](N)CC(O)=O)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N[C@H](C(N[C@H](C(O)=O)C(C)C)=O)C(C)C)=O)=O)=O)C(C)C)=O)CCSC)=O)CC(C)C)=O)=O)[C@H](CC)C)=O)[C@H](CC)C)=O)C)=O)=O)CCCCN)=O)CC(N)=O)=O)CO)=O)=O)C(C)C)=O)CC(N)=O)=O)CCC(N)=O)=O)C)=O)CC1=CC=CC=C1)=O)CC2=CC=CC=C2)=O)C(C)C)=O)CC(C)C)=O)CCCCN)=O)CCC(N)=O)=O)CC3=CNC=N3)=O)CC4=CNC=N4)=O)C(C)C)=O)CCC(O)=O)=O)CC5=CC=C(O)C=C5)=O)=O)CO)=O)CC(O)=O)=O)CC6=CNC=N6)=O)CCCNC(N)=N)=O)CC7=CC=CC=C7)=O)CCC(O)=O)=O)C

Molecular Formula

C194H297N55O56S

Molecular Weight

4327.83

References & Citations

[1]Van Nostrand WE, et al. Pathogenic effects of cerebral amyloid angiopathy mutations in the amyloid beta-protein precursor. Ann N Y Acad Sci. 2002 Nov;977:258-65.